Supplementary Methods

Cell culture and transfections
HeLa cells were used unless otherwise indicated. Cells were cultured in DME medium supplemented with 10% fetal bovine serum. For synchronization at the G1/S boundary, cells were cultured in the presence of 2 mM thymidine for 18 h. For synchronization at M phase, cells were cultured in the presence of 2 mM thymidine for 18 h, washed once with PBS, cultured in fresh medium for 3 h, and then cultured in the presence of 100 ng/ml nocodazole or 1 μM taxol for 12 h. Transfection of siRNA oligonucleotides was carried out by incubating 100 nM duplexed siRNA with RNAi MAX (Invitrogen) in antibiotic-free growth medium. For control transfections, the same annealing reaction was performed using H 2 O instead of siRNA oligos. Transfection of expression plasmids was performed using FuGENE 6 Transfection Reagent (Roche Applied Science).
Rescue experiments were performed by transfecting siRNA-treated cells 36 h later with the indicated expression plasmids using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. Cells were observed 24 h after transfection of the expression plasmids.
Plasmid construction
The cDNAs coding for human MAD2L2 and CAMP were PCR-amplified from a human brain cDNA library. The cDNAs were subcloned into pcDNA5/FRT (Invitrogen), pGEX-4T3, or pEGFP-C1 (Clontech) expression vectors. The expression plasmids for CAMP deletion mutants were constructed using PCR amplification. The expression plasmids for non-phosphorylatable CAMP mutants and RNAi-resistant CAMP constructs were constructed using the QuikChange Multi Site-Directed Mutagenesis Kit (Stratagene).
Generation of cell lines, immunoprecipitation (IP), and nanoflow liquid chromatography tandem mass spectrometry (nano-LC/MS/MS)
Cell lines stably expressing Flag-MAD2L2 were established using the Flp-In system (Invitrogen) according to the manufacturer's instructions. were transfected with the Flag-MAD2L2 expression vector using FuGENE 6 Transfection Reagent and selected for hygromycin resistance. IP was carried out with anti-Flag M2 affinity gel (Sigma) as previously described (Hong et al, 2008) . The IP product was separated by SDS-PAGE and stained using a silver stain kit (Wako).
Protein bands were excised from the gels, digested with trypsin and subjected to nano-LC/MS/MS analysis as described previously (Hong et al, 2008) .
Immunoprecipitation
Cells were lysed in IP buffer (20 mM Tris (pH 7.5), 150 mM NaCl, 20 mM -glycerophosphate, 5 mM MgCl 2 , 0.1% NP-40, 5% glycerol) supplemented with protease inhibitor cocktails (Complete Mini EDTA-free, Roche Diagnostics) and phosphatase inhibitors (Wako), and cleared by centrifugation for 30 min at 4˚C at 13,000 rpm. After preclearing with sheep anti-rabbit IgG conjugated to magnetic beads (Dynabeads M-280, Invitrogen), the lysates were incubated with anti-CAMP antibody (3 μg) for 1 h in the presence of RNase A and DNase I at 4 , followed by incubation with anti-rabbit IgG conjugated to magnetic beads for 2 h at 4˚C. After washing twice with IP buffer and twice with TBS containing 0.1% Tween 20, the beads were suspended in SDS-PAGE sample buffer and subjected to western blotting.
Western blotting
Cells were lysed in IP buffer supplemented with protease and phosphatase inhibitors.
Protein concentration was measured and adjusted by the Bradford method (Protein Assay system, Bio-Rad Laboratories), and the cell extracts were resolved by SDS-PAGE and transferred to a PVDF membrane (Immobilon-P, Millipore). Blocking and antibody incubations were performed in 5% non-fat dry milk. Horseradish peroxidase-labelled secondary antibodies (Santa Cruz) were visualized by chemiluminescence using luminal and couramic acid (Amersham).
Far western assay
GST-recombinant proteins were separated by SDS-PAGE and transferred to a PVDF membrane. After the transferred proteins were renatured with guanidine hydrochloride, the membrane was blocked in 5% non-fat dry milk and incubated with 1 μg/ml His-MAD2L2 overnight at 4˚C. After extensive washing, the membrane was subjected to western blotting with an anti-His antibody. HeLa cells were treated as in Figure 6D and stained for Hec1 (green), CENP-E or CENP-F (red), and DNA (blue). The GFP-CAMP signal was also detected in the green channel. Scale bar = 10 μm.
Supplementary Movies
Supplementary Movie 1. Live cell imaging of a mock-treated HeLa cell expressing H2B-GFP. Stills of this movie are displayed in Figure 3A . Images were collected every 3 min, and the display rate is 10 frames/s. 
